Genenta Science S.p.A. American Depositary Shares (GNTA)

Genenta Science has entered into a securities purchase agreement to sell 4,285,715 American Depositary Shares at $3.50 per share, raising approximately $15 million for working capital and general corporate purposes.

The article discusses recent advancements in cancer research and treatment, including promising results from clinical trials of various cancer therapies developed by companies like Oncolytics Biotech, Celcuity, Genenta Science, Sellas Life Sciences, and Amgen.